CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting

ConferencepositiveSurabgene LomparvovecPositive
AI Analysis

Summary

REGENXBIO presented positive long-term data for surabgene lomparvovec in wet AMD and diabetic retinopathy at the American Society of Retina Specialists Annual Meeting.

Outcome Details

Positive long-term data presented

Importance:6/10
Sentiment:
0.70
gene therapyretinal diseaselong-term dataconference presentation
Related Companies

Read the original article

Published by yahoo_finance on July 18, 2026 6:55 PM

Read Original